MET and breast carcinoma: COPG1 was not reported in TWAS or PWAS for breast cancer, but reducing the expression of the COPG1 gene lessened the accumulation of full-length nuclear c-MET, a receptor tyrosine kinase commonly overexpressed in various malignant cancers, including breast cancer [42].